Cyclin-dependent kinase inhibitors enhance programmed cell death protein 1 immune checkpoint blockade efficacy in triple-negative breast cancer by affecting the immune microenvironment.

Jia-Yi Wu Wei Wang Lu Gao Xiying Shao Xiaojia Wang

Published in: Cancer (2024)

Combination therapy with CDK and PD-L1 immune checkpoint inhibitors affects the immune microenvironment, promotes antitumor immunity, and improves the efficacy of immunotherapy for TNBC.

Keyphrases

combination therapy
cell cycle
stem cells
protein protein
amino acid
binding protein
small molecule
cell death
pi k akt